ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“How can AI-enabled clinical trials help make cancer research more inclusive?
One of the terms in our AI and Digital Oncology word cloud, AI-enabled clinical trials, leverage digital tools to optimise patient recruitment, stratification, and monitoring. These approaches support broader patient participation, reduce disparities, and improve representation in oncology research.
Understanding these methods helps researchers design studies that are both efficient and equitable.
Explore this concept and discover insights, research updates and experts’ perspectives on AI at the intersection with oncology in the ESMO AI and Digital Oncology Hub.”
More posts featuring Cancer Research.